<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Solesence, Inc. Common Stock — News on 6ix</title>
<link>https://6ix.com/company/solesence-inc-common-stock</link>
<description>Latest news and press releases for Solesence, Inc. Common Stock on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Apr 2026 20:01:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/solesence-inc-common-stock" rel="self" type="application/rss+xml" />
<item>
<title>Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/solesence-to-report-first-quarter-2026-financial-results-and-host-a-conference-call-on-may-12</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/solesence-to-report-first-quarter-2026-financial-results-and-host-a-conference-call-on-may-12</guid>
<pubDate>Tue, 28 Apr 2026 20:01:00 GMT</pubDate>
<description>ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2026 after the market opens on Tuesday, May 12, 2026, and host a conference call and webcast on the same date. First Quarter 2026 Conference Call DetailsDate/Time: Tuesday, May 12, 2026 – 7:30 a.m. CT, 8:30 a.m. ET Speakers: Kevin Cureton</description>
</item>
<item>
<title>Solésence, Inc. Announces Appointment of New Independent Director</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/solesence-inc-announces-appointment-of-new-independent-director</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/solesence-inc-announces-appointment-of-new-independent-director</guid>
<pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
<description>Marc James to Join Board of Directors and Serve on Audit, Compensation, and Nominating Committees ROMEOVILLE, Ill., April 27, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced the appointment of Marc James to its Board of Directors as an independent director, effective immediately. James will also serve as a member of the Company’s Audit Committee, Compensation Committee, and</description>
</item>
<item>
<title>Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/solesence-reports-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/solesence-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Tue, 31 Mar 2026 04:00:00 GMT</pubDate>
<description>Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in</description>
</item>
<item>
<title>Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/solesence-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-a-conference-call-on-march-31-2026</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/solesence-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-a-conference-call-on-march-31-2026</guid>
<pubDate>Thu, 19 Mar 2026 04:00:00 GMT</pubDate>
<description>ROMEOVILLE, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and</description>
</item>
<item>
<title>Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/yoolie-park-joins-solesence-inc-as-vice-president-of-brand-partnerships</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/yoolie-park-joins-solesence-inc-as-vice-president-of-brand-partnerships</guid>
<pubDate>Thu, 26 Feb 2026 05:00:00 GMT</pubDate>
<description>Park brings over 20 years of industry experience to expand innovation and drive brand partner growth ROMEOVILLE, Ill., Feb. 26, 2026 (GLOBE NEWSWIRE) --</description>
</item>
<item>
<title>Solésence Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-reports-third-quarter-120000787</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-reports-third-quarter-120000787</guid>
<pubDate>Tue, 11 Nov 2025 12:00:00 GMT</pubDate>
<description>Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the third quarter ended September 30, 2025. Recent Highlights and Accomplishments Continued strategic transformation to drive future innovation and growth with promotio</description>
</item>
<item>
<title>Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-inc-appoints-yoana-130000000</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-inc-appoints-yoana-130000000</guid>
<pubDate>Mon, 10 Nov 2025 13:00:00 GMT</pubDate>
<description>Dvorzsak to oversee product quality and drive innovation to support growth amidst evolving consumer needs; Named a Cosmetic Executive Women (CEW) Innovator Honoree ROMEOVILLE, Ill., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoana Dvorzsak to the newly created role of Vice President of Innovation and Product Integrity to support the Compan</description>
</item>
<item>
<title>Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-report-third-quarter-120000002</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-report-third-quarter-120000002</guid>
<pubDate>Thu, 30 Oct 2025 12:00:00 GMT</pubDate>
<description>ROMEOVILLE, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the third quarter of 2025 before the market opens on Tuesday, November 11, 2025, and host a conference call and webcast on the same date. Third Quarter 2025 Conference Call DetailsDate / Time: Tuesday, November 11, 2025 – 7:30 a.m. CDT, 8:30 a.m. EDT Speakers:</description>
</item>
<item>
<title>Solésence Announces Key Leadership Appointments to Drive Future Innovation and Growth</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-announces-key-leadership-120000654</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-announces-key-leadership-120000654</guid>
<pubDate>Wed, 03 Sep 2025 12:00:00 GMT</pubDate>
<description>Strategic transformation of Solésence continues with Kevin Cureton promoted to President and Chief Executive Officer; Laura Riffner named Chief Financial Officer; Jess Jankowski to serve as Board AdvisorROMEOVILLE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced strategic changes to its executive leadership. Kevin Cureton, a driving force behind the company’</description>
</item>
<item>
<title>Solésence Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-reports-second-quarter-200100306</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-reports-second-quarter-200100306</guid>
<pubDate>Thu, 31 Jul 2025 20:01:00 GMT</pubDate>
<description>Strong commercial execution drove revenue growth of 56% to $20.4 millionROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the second quarter ended June 30, 2025. Recent Highlights and Accomplishments Joined broad-market Russell 3000® and small-cap Russell 2000® IndexesAmended loan agreements to fuel growth initiatives “During o</description>
</item>
<item>
<title>Solésence To Report Second Quarter 2025 Financial Results and Host a Conference Call</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-report-second-quarter-120000971</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-report-second-quarter-120000971</guid>
<pubDate>Thu, 24 Jul 2025 12:00:00 GMT</pubDate>
<description>ROMEOVILLE, Ill., July 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2025 after the market close on Thursday, July 31, 2025, and host a conference call and webcast on the same date. Second Quarter 2025 Conference Call Details Date / Time: Thursday, July 31, 2025 - 4:00 p.m. CDT, 5:00 p.m. EDT Speakers: Jes</description>
</item>
<item>
<title>Solésence to Join Russell 3000® and Russell 2000® Indexes</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-join-russell-3000-120000673</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-join-russell-3000-120000673</guid>
<pubDate>Tue, 24 Jun 2025 12:00:00 GMT</pubDate>
<description>ROMEOVILLE, Ill., June 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it will be added as a member of the broad-market Russell 3000® and small-cap Russell 2000® Indexes, effective after the U.S. market opens on June 30, as part of the 2025 Russell indexes reconstitution. The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of</description>
</item>
<item>
<title>Solésence Expands Debt Facilities to Fuel Growth Initiatives</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-expands-debt-facilities-120000299</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-expands-debt-facilities-120000299</guid>
<pubDate>Mon, 02 Jun 2025 12:00:00 GMT</pubDate>
<description>ROMEOVILLE, Ill., June 02, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it entered into amendments on May 27, 2025 to its existing loan agreements, providing increased borrowing capacity to support the execution of strategic objectives. The new facility expands the Company’s three loan agreements to a maximum borrowing capacity from $14.2 million to $23.0 million an</description>
</item>
<item>
<title>Solésence Reports Record First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-reports-record-first-200100126</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-reports-record-first-200100126</guid>
<pubDate>Mon, 05 May 2025 20:01:00 GMT</pubDate>
<description>First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2025. Recent Highlights and Accomplishments Uplisted to Nasdaq under the ticker “SLSN” supporting the Company’s increased visibility with the investment communityAchieved record revenu</description>
</item>
<item>
<title>Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call</title>
<link>https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-report-first-quarter-200100647</link>
<guid isPermaLink="true">https://6ix.com/company/solesence-inc-common-stock/news/sol-sence-report-first-quarter-200100647</guid>
<pubDate>Mon, 28 Apr 2025 20:01:00 GMT</pubDate>
<description>ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2025 after the market close on Monday, May 5, 2025, and host a conference call and webcast on the same date. First Quarter 2025 Conference Call Details Date / Time: Monday, May 5, 2025 - 4:00 p.m. CDT, 5</description>
</item>
</channel>
</rss>